{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:53:55Z","timestamp":1794020035793,"version":"4.8.0"},"reference-count":111,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adult T-cell leukemia\/lymphoma (ATL) is an aggressive malignancy of mature activated T cells caused by human T-cell lymphotropic virus type I. ATL carries a bad prognosis because of intrinsic chemoresistance and severe immunosuppression. In acute ATL, Japanese trials demonstrated that although combinations of chemotherapy improved response rate, they failed to achieve a significant impact on survival. Patients with chronic and smoldering ATL have a better prognosis, but long-term survival is poor when these patients are managed with a watchful-waiting policy or with chemotherapy. Recently, a worldwide meta-analysis revealed that the combination of zidovudine and IFN-\u03b1 is highly effective in the leukemic subtypes of ATL and should be considered as standard first-line therapy in that setting. This combination has changed the natural history of the disease through achievement of significantly improved long-term survival in patients with smoldering and chronic ATL as well as a subset of patients with acute ATL. ATL lymphoma patients still benefit from chemotherapy induction with concurrent or sequential antiretroviral therapy with zidovudine\/IFN. To prevent relapse, clinical trials assessing consolidative targeted therapies such as arsenic\/IFN combination or novel monoclonal antibodies are needed. Finally, allogeneic BM transplantation should be considered in suitable patients.<\/jats:p>","DOI":"10.1182\/blood-2011-03-345702","type":"journal-article","created":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T05:36:19Z","timestamp":1308116179000},"page":"1736-1745","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":145,"title":["How I treat adult T-cell leukemia\/lymphoma"],"prefix":"10.1182","volume":"118","author":[{"given":"Ali","family":"Bazarbachi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, American University of Beirut, Beirut, Lebanon;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Suarez","sequence":"additional","affiliation":[{"name":"Centre Nationale de Recherche Scientifique Unit\u00e9 Mixte de Recherche 8147 and Department of Hematology, Necker Hospital, Paris Descartes University, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fields","sequence":"additional","affiliation":[{"name":"Department of Haematology, Guys and St Thomas Hospital, Kings Health Partners, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[{"name":"Centre Nationale de Recherche Scientifique Unit\u00e9 Mixte de Recherche 8147 and Department of Hematology, Necker Hospital, Paris Descartes University, Paris, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111808023607800_B1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.bloodjournal503481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases.","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"issue":"11","key":"2019111808023607800_B2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1470-2045(04)01608-0","article-title":"New therapeutic approaches for adult T-cell leukaemia.","volume":"5","author":"Bazarbachi","year":"2004","journal-title":"Lancet Oncol"},{"key":"2019111808023607800_B3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/rmv.1980030304","article-title":"The epidemiology of human T-lymphotropic virus types I and II.","volume":"3","author":"Kaplan","year":"1993","journal-title":"Med Virol"},{"issue":"2","key":"2019111808023607800_B4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-0609.1994.tb01297.x","article-title":"HTLV-I in Romania.","volume":"52","author":"Paun","year":"1994","journal-title":"Eur J Haematol"},{"key":"2019111808023607800_B5","first-page":"33","article-title":"Epidemiology of HTLV-1 and associated disease.","volume-title":"Human T-Cell Lymphotropic Virus Type 1","author":"Gessain","year":"1996"},{"issue":"6","key":"2019111808023607800_B6","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1128\/JCM.41.6.2593-2595.2003","article-title":"Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran.","volume":"41","author":"Abbaszadegan","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2019111808023607800_B7","first-page":"409","article-title":"Disease association, genetics, and biology of human T-cell lymphotropic virus types I and II.","volume-title":"Viral Disease in Hematology","author":"Franchini","year":"2000"},{"issue":"10","key":"2019111808023607800_B8","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1182\/blood.V86.10.3619.bloodjournal86103619","article-title":"Molecular mechanisms of human T-cell leukemia\/lymphotropic virus type I infection.","volume":"86","author":"Franchini","year":"1995","journal-title":"Blood"},{"issue":"5","key":"2019111808023607800_B9","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/JVI.69.5.2863-2868.1995","article-title":"Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy.","volume":"69","author":"Wattel","year":"1995","journal-title":"J Virol"},{"key":"2019111808023607800_B10","first-page":"4559s","article-title":"Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.","volume":"45","author":"Waldmann","year":"1985","journal-title":"Cancer Res"},{"issue":"2","key":"2019111808023607800_B11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1128\/JVI.75.2.1083-1089.2001","article-title":"Two-step nature of human T-cell leukemia virus type 1 replication in experimentally infected squirrel monkeys (Saimiri sciureus).","volume":"75","author":"Mortreux","year":"2001","journal-title":"J Virol"},{"issue":"7","key":"2019111808023607800_B12","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.163.7.4064","article-title":"Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2\/15R beta receptor.","volume":"163","author":"Azimi","year":"1999","journal-title":"J Immunol"},{"key":"2019111808023607800_B13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.immunol.19.1.475","article-title":"Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.","volume":"19","author":"Yoshida","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"2019111808023607800_B14","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.cdd.4401624","article-title":"Proapoptotic regimes for HTLV-I\u2013transformed cells: targeting Tax and the NF-kappaB pathway.","volume":"12","author":"Kfoury","year":"2005","journal-title":"Cell Death Differ"},{"issue":"39","key":"2019111808023607800_B15","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","article-title":"Molecular mechanisms of cellular transformation by HTLV-1 Tax.","volume":"24","author":"Grassmann","year":"2005","journal-title":"Oncogene"},{"issue":"4","key":"2019111808023607800_B16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/carcin\/bgi274","article-title":"Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.","volume":"27","author":"Tabakin-Fix","year":"2006","journal-title":"Carcinogenesis"},{"issue":"6","key":"2019111808023607800_B17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10495-008-0208-7","article-title":"HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.","volume":"13","author":"Taylor","year":"2008","journal-title":"Apoptosis"},{"issue":"1","key":"2019111808023607800_B18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-8674(00)81148-4","article-title":"Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1.","volume":"93","author":"Jin","year":"1998","journal-title":"Cell"},{"key":"2019111808023607800_B19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-4690-5-76","article-title":"The HTLV-1 Tax interactome.","volume":"5","author":"Boxus","year":"2008","journal-title":"Retrovirology"},{"key":"2019111808023607800_B20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1742-4690-2-54","article-title":"The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix.","volume":"2","author":"Fraedrich","year":"2005","journal-title":"Retrovirology"},{"issue":"4","key":"2019111808023607800_B21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2019111808023607800_B22","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2005-09-3572","article-title":"Tax ubiquitylation and sumoylation control critical cytoplasmic and nuclear steps of NF-kappaB activation.","volume":"107","author":"Nasr","year":"2006","journal-title":"Blood"},{"issue":"23","key":"2019111808023607800_B23","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1128\/MCB.25.23.10391-10406.2005","article-title":"Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein.","volume":"25","author":"Lamsoul","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"12","key":"2019111808023607800_B24","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/sj.onc.1210804","article-title":"Ubiquitylated Tax targets and binds the IKK signalosome at the centrosome.","volume":"27","author":"Kfoury","year":"2008","journal-title":"Oncogene"},{"issue":"1","key":"2019111808023607800_B25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2010-05-285742","article-title":"Tax ubiquitylation and SUMOylation control the dynamic shuttling of Tax and NEMO between Ubc9 nuclear bodies and the centrosome.","volume":"117","author":"Kfoury","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019111808023607800_B26","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1182\/blood.V99.9.3383","article-title":"Human T-cell lymphotropic virus type 1\u2013transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells.","volume":"99","author":"El-Sabban","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2019111808023607800_B27","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1158\/0008-5472.CAN-03-2390","article-title":"Human T-cell lymphotropic virus type I\u2013infected cells extravasate through the endothelial barrier by a local angiogenesis-like mechanism.","volume":"64","author":"Bazarbachi","year":"2004","journal-title":"Cancer Res"},{"issue":"12","key":"2019111808023607800_B28","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1182\/blood-2001-12-0372","article-title":"Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis.","volume":"100","author":"Arnulf","year":"2002","journal-title":"Blood"},{"issue":"1400","key":"2019111808023607800_B29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1098\/rstb.2000.0638","article-title":"Is human T-cell lymphotropic virus type I really silent?","volume":"355","author":"Asquith","year":"2000","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"19","key":"2019111808023607800_B30","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1073\/pnas.81.19.6207","article-title":"Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia.","volume":"81","author":"Franchini","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2019111808023607800_B31","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1073\/pnas.87.13.5218","article-title":"Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.","volume":"87","author":"Tendler","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2019111808023607800_B32","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/JVI.65.3.1628-1633.1991","article-title":"Human T-cell leukemia-lymphoma virus type I (HTLV-I) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparesis\/HTLV-I-associated myelopathy.","volume":"65","author":"Gessain","year":"1991","journal-title":"J Virol"},{"key":"2019111808023607800_B33","first-page":"5697S","article-title":"Chromosome and gene rearrangements in immortalized human lymphocytes infected with human T-lymphotropic virus type I.","volume":"50","author":"Maruyama","year":"1990","journal-title":"Cancer Res"},{"issue":"2","key":"2019111808023607800_B34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V79.2.477.477","article-title":"Mutations of the p53 gene in adult T-cell leukemia.","volume":"79","author":"Sakashita","year":"1992","journal-title":"Blood"},{"issue":"24","key":"2019111808023607800_B35","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1038\/sj.onc.1206468","article-title":"Inactivation of hTERT transcription by Tax.","volume":"22","author":"Gabet","year":"2003","journal-title":"Oncogene"},{"issue":"9","key":"2019111808023607800_B36","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/ijc.22026","article-title":"Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.","volume":"119","author":"Bellon","year":"2006","journal-title":"Int J Cancer"},{"issue":"4","key":"2019111808023607800_B37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nm1389","article-title":"Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.","volume":"12","author":"Hasegawa","year":"2006","journal-title":"Nat Med"},{"issue":"4","key":"2019111808023607800_B38","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.V98.4.1200","article-title":"The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors.","volume":"98","author":"Portis","year":"2001","journal-title":"Blood"},{"issue":"4","key":"2019111808023607800_B39","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1128\/JVI.01513-06","article-title":"Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.","volume":"81","author":"Banerjee","year":"2007","journal-title":"J Virol"},{"issue":"1","key":"2019111808023607800_B40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.leu.2403176","article-title":"Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1\u2013infected patients with adult T-cell leukemia\/lymphoma.","volume":"18","author":"Arnulf","year":"2004","journal-title":"Leukemia"},{"issue":"3","key":"2019111808023607800_B41","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.","volume":"103","author":"Satou","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111808023607800_B42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1742-4690-6-71","article-title":"The HBZ gene, a key player in HTLV-1 pathogenesis.","volume":"6","author":"Matsuoka","year":"2009","journal-title":"Retrovirology"},{"key":"2019111808023607800_B43","author":"Swerdlow","year":"2008","journal-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues"},{"issue":"3","key":"2019111808023607800_B44","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"2019111808023607800_B45","first-page":"147","article-title":"Adult T-cell leukemia\/lymphoma.","author":"Takatsuki","year":"1990","journal-title":"Retrovirus Biology and Human Disease"},{"issue":"6","key":"2019111808023607800_B46","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/1097-0142(19870315)59:6<1187::AID-CNCR2820590626>3.0.CO;2-8","article-title":"Hypercalcemia and osteoclast proliferation in adult T-cell leukemia.","volume":"59","author":"Kiyokawa","year":"1987","journal-title":"Cancer"},{"issue":"5","key":"2019111808023607800_B47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM198308043090501","article-title":"Clinical course of retrovirus-associated adult T-cell lymphoma in the United States.","volume":"309","author":"Bunn","year":"1983","journal-title":"N Engl J Med"},{"issue":"4","key":"2019111808023607800_B48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1473-3099(07)70081-6","article-title":"Human T-lymphotropic virus 1: recent knowledge about an ancient infection.","volume":"7","author":"Verdonck","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"2019111808023607800_B49","first-page":"1834","article-title":"A new classification of clinical stages of adult T-cell leukemia based on prognosis of the disease.","volume":"8","author":"Shirono","year":"1994","journal-title":"Leukemia"},{"issue":"2","key":"2019111808023607800_B50","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","article-title":"A new G-CSF\u2013supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.","volume":"113","author":"Yamada","year":"2001","journal-title":"Br J Haematol"},{"key":"2019111808023607800_B51","doi-asserted-by":"crossref","article-title":"Smouldering adult T-cell leukaemia\/lymphoma (ATLL) Is not associated with an increased risk of aggressive ATLL In HTLV-1 positive patients.","author":"Hodson","DOI":"10.1182\/blood.V116.21.4167.4167"},{"issue":"22","key":"2019111808023607800_B52","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2009-09-242347","article-title":"Long-term study of indolent adult T-cell leukemia-lymphoma.","volume":"115","author":"Takasaki","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111808023607800_B53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting.","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111808023607800_B54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ijc.2910350111","article-title":"HTLV-positive and -negative T-cell lymphomas. Morphological and immunohistochemical differences between European and HTLV-positive Japanese T-cell lymphomas.","volume":"35","author":"Lennert","year":"1985","journal-title":"Int J Cancer"},{"issue":"4","key":"2019111808023607800_B55","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2141.1998.00761.x","article-title":"Nodal T-cell lymphoma in an HTLV-I-endemic area: proviral HTLV-I DNA, histological classification and clinical evaluation.","volume":"101","author":"Ohshima","year":"1998","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111808023607800_B56","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00320296","article-title":"Adult T-cell leukemia with an unusual phenotype, Leu-2a positive and Leu-3a negative.","volume":"50","author":"Amagasaki","year":"1985","journal-title":"Blut"},{"issue":"9","key":"2019111808023607800_B57","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood.V84.9.3080.3080","article-title":"A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction.","volume":"84","author":"Takemoto","year":"1994","journal-title":"Blood"},{"issue":"5\u20136","key":"2019111808023607800_B58","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/10428199609054793","article-title":"Adult T-cell leukemia (ATL) with an unusual immunophenotype and a high cellular proliferation rate.","volume":"22","author":"Lorand-Metze","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"2019111808023607800_B59","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood.V89.3.948","article-title":"Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease.","volume":"89","author":"Tsukasaki","year":"1997","journal-title":"Blood"},{"issue":"4","key":"2019111808023607800_B60","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/1097-0142(19880215)61:4<824::AID-CNCR2820610430>3.0.CO;2-6","article-title":"Adult T-cell leukemia with leukemia cell infiltration into the gastrointestinal tract.","volume":"61","author":"Utsunomiya","year":"1988","journal-title":"Cancer"},{"issue":"6","key":"2019111808023607800_B61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00063030-199810060-00003","article-title":"Adult T cell leukaemia: a review of established and new treatments.","volume":"10","author":"Hermine","year":"1998","journal-title":"BioDrugs"},{"issue":"1\u20132","key":"2019111808023607800_B62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0168-1702(01)00286-6","article-title":"Treatment of adult T-cell leukaemia\/lymphoma: current strategy and future perspectives.","volume":"78","author":"Bazarbachi","year":"2001","journal-title":"Virus Res"},{"issue":"14","key":"2019111808023607800_B63","first-page":"1250","article-title":"Current management of adult T-cell leukemia\/lymphoma.","volume":"23","author":"Tobinai","year":"2009","journal-title":"Oncology (Williston Park)"},{"issue":"16","key":"2019111808023607800_B64","first-page":"746","article-title":"Adult T-cell leukemia and non-malignant adenopathies associated with HTLV I virus. Apropos of 17 patients born in the Caribbean region and Africa [in French].","volume":"19","author":"Rio","year":"1990","journal-title":"Presse Med"},{"issue":"2","key":"2019111808023607800_B65","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/00042560-199606010-00012","article-title":"An intensive chemotherapy of adult T-cell leukemia\/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.","volume":"12","author":"Taguchi","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"5","key":"2019111808023607800_B66","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/bjc.1991.423","article-title":"Deoxycoformycin in the treatment of mature T-cell leukaemias.","volume":"64","author":"Dearden","year":"1991","journal-title":"Br J Cancer"},{"issue":"3","key":"2019111808023607800_B67","first-page":"164","article-title":"Phase I study of YK-176 (2\u2032-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. The DCF Study Group.","volume":"22","author":"Tobinai","year":"1992","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"2019111808023607800_B68","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF02983215","article-title":"Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).","volume":"77","author":"Tsukasaki","year":"2003","journal-title":"Int J Hematol"},{"issue":"4","key":"2019111808023607800_B69","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/bjc.1994.394","article-title":"Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy.","volume":"70","author":"Tsuda","year":"1994","journal-title":"Br J Cancer"},{"issue":"18","key":"2019111808023607800_B70","first-page":"4903","article-title":"Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.","volume":"51","author":"Tanabe","year":"1991","journal-title":"Cancer Res"},{"issue":"10","key":"2019111808023607800_B71","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1182\/blood.V76.10.2065.2065","article-title":"Expression of P-glycoprotein in adult T-cell leukemia cells.","volume":"76","author":"Kuwazuru","year":"1990","journal-title":"Blood"},{"issue":"7","key":"2019111808023607800_B72","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood.V91.7.2467","article-title":"Enhanced MDR1 gene expression in human T-cell leukemia virus-I-infected patients offers new prospects for therapy.","volume":"91","author":"Lau","year":"1998","journal-title":"Blood"},{"issue":"1","key":"2019111808023607800_B73","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.93.1.265","article-title":"Induction of the WAF1\/CIP1 protein and apoptosis in human T-cell leukemia virus type I-transformed lymphocytes after treatment with adriamycin by using a p53-independent pathway.","volume":"93","author":"Gartenhaus","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2019111808023607800_B74","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V82.6.1701.1701","article-title":"The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.","volume":"82","author":"Waldmann","year":"1993","journal-title":"Blood"},{"issue":"11","key":"2019111808023607800_B75","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V86.11.4063.bloodjournal86114063","article-title":"Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90\u2013labeled anti-Tac.","volume":"86","author":"Waldmann","year":"1995","journal-title":"Blood"},{"issue":"1","key":"2019111808023607800_B76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.leukres.2005.05.008","article-title":"Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin.","volume":"30","author":"Ravandi","year":"2006","journal-title":"Leuk Res"},{"issue":"10","key":"2019111808023607800_B77","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood-2005-01-0335","article-title":"Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine\/IFN-{alpha}-refractory adult T-cell leukemia.","volume":"106","author":"Mone","year":"2005","journal-title":"Blood"},{"issue":"5","key":"2019111808023607800_B78","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood-2003-07-2440","article-title":"A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients.","volume":"103","author":"Moura","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111808023607800_B79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.leu.2404958","article-title":"Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody.","volume":"22","author":"Callens","year":"2008","journal-title":"Leukemia"},{"issue":"9","key":"2019111808023607800_B80","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","article-title":"Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.","volume":"28","author":"Yamamoto","year":"2010","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111808023607800_B81","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1182\/blood-2002-11-3601","article-title":"Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD2 monoclonal antibody, MEDI-507.","volume":"102","author":"Zhang","year":"2003","journal-title":"Blood"},{"issue":"1","key":"2019111808023607800_B82","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1701533","article-title":"Poor outcome of autologous stem cell transplantation for adult T cell leukemia\/lymphoma: a case report and review of the literature.","volume":"23","author":"Tsukasaki","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2019111808023607800_B83","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/10428190902887571","article-title":"A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia\/lymphoma suggests ineffective salvage of relapsed patients.","volume":"50","author":"Phillips","year":"2009","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"2019111808023607800_B84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bmt.1702731","article-title":"Improved outcome of adult T cell leukemia\/lymphoma with allogeneic hematopoietic stem cell transplantation.","volume":"27","author":"Utsunomiya","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111808023607800_B85","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2141.2003.04054.x","article-title":"Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia\/lymphoma.","volume":"120","author":"Kami","year":"2003","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111808023607800_B86","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.leu.2403682","article-title":"Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia\/lymphoma.","volume":"19","author":"Fukushima","year":"2005","journal-title":"Leukemia"},{"issue":"10","key":"2019111808023607800_B87","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood-2004-11-4193","article-title":"Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia\/lymphoma.","volume":"105","author":"Okamura","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2019111808023607800_B88","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood-2009-10-247510","article-title":"Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.","volume":"116","author":"Hishizawa","year":"2010","journal-title":"Blood"},{"issue":"26","key":"2019111808023607800_B89","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","article-title":"Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.","volume":"332","author":"Gill","year":"1995","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111808023607800_B90","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","article-title":"Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.","volume":"332","author":"Hermine","year":"1995","journal-title":"N Engl J Med"},{"key":"2019111808023607800_B91","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1097\/00042560-199600001-00028","article-title":"Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia\/lymphoma patients.","author":"Bazarbachi","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"3\u20134","key":"2019111808023607800_B92","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/10428190109057927","article-title":"The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia\/lymphoma.","volume":"40","author":"White","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2019111808023607800_B93","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.thj.6200195","article-title":"A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma.","volume":"3","author":"Hermine","year":"2002","journal-title":"Hematol J"},{"issue":"3","key":"2019111808023607800_B94","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2141.2001.02794.x","article-title":"Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.","volume":"113","author":"Matutes","year":"2001","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111808023607800_B95","doi-asserted-by":"crossref","first-page":"e4420","DOI":"10.1371\/journal.pone.0004420","article-title":"Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.","volume":"4","author":"Ratner","year":"2009","journal-title":"PLoS ONE"},{"issue":"12","key":"2019111808023607800_B96","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1080\/1042819021000039983","article-title":"Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.","volume":"43","author":"Besson","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"27","key":"2019111808023607800_B97","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","article-title":"Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes.","volume":"28","author":"Bazarbachi","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111808023607800_B98","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/sj.thj.6200374","article-title":"Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed\/refractory adult T-cell leukemia\/lymphoma.","volume":"5","author":"Hermine","year":"2004","journal-title":"Hematol J"},{"issue":"26","key":"2019111808023607800_B99","doi-asserted-by":"crossref","first-page":"6528","DOI":"10.1182\/blood-2009-03-211821","article-title":"Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL).","volume":"113","author":"Kchour","year":"2009","journal-title":"Blood"},{"issue":"7","key":"2019111808023607800_B100","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1182\/blood-2006-07-036368","article-title":"IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia\/lymphoma.","volume":"109","author":"Ramos","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111808023607800_B101","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10428190601071717","article-title":"Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.","volume":"48","author":"Kchour","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2019111808023607800_B102","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1309\/2YGD1P0QCVCWBLDX","article-title":"Adult T-cell leukemia\/lymphoma in Bahia, Brazil: analysis of prognostic factors in a group of 70 patients.","volume":"128","author":"Bittencourt","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2019111808023607800_B103","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood.V93.1.278","article-title":"Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells.","volume":"93","author":"Bazarbachi","year":"1999","journal-title":"Blood"},{"issue":"8","key":"2019111808023607800_B104","first-page":"2849","article-title":"Arsenic-interferon-alpha-triggered apoptosis in HTLV-I\u2013transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.","volume":"96","author":"El-Sabban","year":"2000","journal-title":"Blood"},{"issue":"13","key":"2019111808023607800_B105","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1182\/blood.V98.13.3762","article-title":"Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage.","volume":"98","author":"Mahieux","year":"2001","journal-title":"Blood"},{"issue":"11","key":"2019111808023607800_B106","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1182\/blood-2002-09-2986","article-title":"Arsenic\/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1\u2013infected leukemic cells.","volume":"101","author":"Nasr","year":"2003","journal-title":"Blood"},{"issue":"13","key":"2019111808023607800_B107","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1084\/jem.20101095","article-title":"Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia.","volume":"207","author":"El Hajj","year":"2010","journal-title":"J Exp Med"},{"key":"2019111808023607800_B108","article-title":"Addition of anti-viral therapy to chemotherapy improves overall survival in acute and lymphomatous adult t-cell leukemia\/lymphoma (ATLL).","author":"Hodson","year":"2010"},{"key":"2019111808023607800_B109","first-page":"43","article-title":"Treatment of patients with adult T-cell leukemialymphoma: an overview.","volume-title":"Advances in Adult T-Cell Leukemia and HTLV-I Research","author":"Shimoyama","year":"1992"},{"issue":"3","key":"2019111808023607800_B110","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","article-title":"Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.","volume":"108","author":"Datta","year":"2006","journal-title":"Blood"},{"issue":"34","key":"2019111808023607800_B111","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/7\/1736\/1347813\/zh803311001736.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/118\/7\/1736\/1347813\/zh803311001736.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T11:03:47Z","timestamp":1686135827000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/118\/7\/1736\/29705\/How-I-treat-adult-Tcell-leukemialymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,18]]},"references-count":111,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,8,18]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-03-345702","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,18]]}}}